Jianchun Duan

12PUBLICATIONS
39CO-AUTHORS
Predictive and prognostic markersCounselling psychologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 26, 2024
Prediction performance comparison of biomarkers for response to immune checkpoint inhibitors in advanced non-small cell lung cancer.

Jie Zhao, Wei Zhuang, Boyang Sun

|Mar 25, 2024
Screening for depression and anxiety in lung cancer patients: A real-world study using GAD-7 and HADS.

Yi Fung Chau, Huixia Zhou, Bolu Chen

|Jan 14, 2024
Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer.

Gen Lin, Zhijie Wang, Qian Chu

|Nov 14, 2023
Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancer.

Dingzhi Huang, Gen Lin, Qian Chu

|May 24, 2023
Abnormal activation of NF-κB and MAPK signaling pathways affect osimertinib resistance and influence the recruitment of myeloid-derived suppressor cells to shape the immunosuppressive tumor immune microenvironment.

Chao Wang, Kailun Fei, Lihui Liu

|Sep 28, 2022
Immunotherapy combined with chemotherapy versus chemotherapy alone as the first-line treatment of PD-L1-negative and driver-gene-negative advanced nonsquamous non-small-cell lung cancer: An updated systematic review and meta-analysis.

Yue Chai, Xinyu Wu, Yifeng Zou

Pageof 2

Frequent Collaborators

4 joint publications

Jie Wang

2 joint publications

Xinyang Du

2 joint publications

Yixiang Zhu

2 joint publications

Chengzhi Zhou